Ampio pharmaceuticals' ceo mike martino issues letter to stockholders

Englewood, colo., dec. 16, 2021 /prnewswire/ -- ampio pharmaceuticals (nyse american: ampe), a biopharmaceutical company focused on the advancement of immunology-based therapies for prevalent inflammatory conditions, today released the following letter to stockholders from its chief executive officer, mike martino.
AMPE Ratings Summary
AMPE Quant Ranking